Australia Stock Exchange release from CYNATA THR : New Study to Investigate the High Potency of Cymerus MSCs
01/03/2021 22:21
Australia Stock Exchange release from CYNATA THR CYP.AX : New Study to Investigate the High Potency of Cymerus MSCs
Recent news on Cynata Therapeutics
See all newsBrief: Cynata Therapeutics Says Firm Commitments Received To Raise Further A$550,000 Via Placement
Brief: Cynata Therapeutics Enters Consultancy Agreement With LIR Bio Advisory
Brief: Cynata Therapeutics Establishes Share Sale Facility For Unmarketable Parcel Holders
Brief: Cynata Therapeutics Terminates Of At-The-Market Subscription Deed
Brief: Cynata Therapeutics Posts FY2026 Loss From Ordinary Activities After Tax A$9.1 Million